Salmonella as a vaccine delivery vehicle.

Kenneth L. Roland, Karen E. Brenneman

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

Attenuated Salmonella vaccines can be administered orally to deliver recombinant antigens to mucosal surfaces inducing a protective immune response against a variety of targeted pathogens. A number of exciting new approaches and technologies for attenuated Salmonella vaccines have been developed recently. However, a disconnect remains between results obtained with mice in preclinical studies and results obtained in human clinical trials. This is due to an incomplete understanding of Salmonella Typhi interactions with human hosts and inadequate animal models available for study. In this review, the authors describe recent progress in identifying important differences underlying S. Typhi-host interactions, the development of novel approaches to vaccine design and six recent clinical trials evaluating Salmonella-vectored vaccines.

Original languageEnglish (US)
Pages (from-to)1033-1045
Number of pages13
JournalExpert Review of Vaccines
Volume12
Issue number9
StatePublished - Sep 2013

Fingerprint

Salmonella Vaccines
Salmonella
Attenuated Vaccines
Salmonella typhi
Vaccines
Clinical Trials
Animal Models
Technology
Antigens

ASJC Scopus subject areas

  • Immunology
  • Drug Discovery
  • Pharmacology
  • Molecular Medicine
  • Medicine(all)

Cite this

Roland, K. L., & Brenneman, K. E. (2013). Salmonella as a vaccine delivery vehicle. Expert Review of Vaccines, 12(9), 1033-1045.

Salmonella as a vaccine delivery vehicle. / Roland, Kenneth L.; Brenneman, Karen E.

In: Expert Review of Vaccines, Vol. 12, No. 9, 09.2013, p. 1033-1045.

Research output: Contribution to journalArticle

Roland, KL & Brenneman, KE 2013, 'Salmonella as a vaccine delivery vehicle.', Expert Review of Vaccines, vol. 12, no. 9, pp. 1033-1045.
Roland KL, Brenneman KE. Salmonella as a vaccine delivery vehicle. Expert Review of Vaccines. 2013 Sep;12(9):1033-1045.
Roland, Kenneth L. ; Brenneman, Karen E. / Salmonella as a vaccine delivery vehicle. In: Expert Review of Vaccines. 2013 ; Vol. 12, No. 9. pp. 1033-1045.
@article{5305f23de52c42b69934dacd674b9e7d,
title = "Salmonella as a vaccine delivery vehicle.",
abstract = "Attenuated Salmonella vaccines can be administered orally to deliver recombinant antigens to mucosal surfaces inducing a protective immune response against a variety of targeted pathogens. A number of exciting new approaches and technologies for attenuated Salmonella vaccines have been developed recently. However, a disconnect remains between results obtained with mice in preclinical studies and results obtained in human clinical trials. This is due to an incomplete understanding of Salmonella Typhi interactions with human hosts and inadequate animal models available for study. In this review, the authors describe recent progress in identifying important differences underlying S. Typhi-host interactions, the development of novel approaches to vaccine design and six recent clinical trials evaluating Salmonella-vectored vaccines.",
author = "Roland, {Kenneth L.} and Brenneman, {Karen E.}",
year = "2013",
month = "9",
language = "English (US)",
volume = "12",
pages = "1033--1045",
journal = "Expert Review of Vaccines",
issn = "1476-0584",
publisher = "Expert Reviews Ltd.",
number = "9",

}

TY - JOUR

T1 - Salmonella as a vaccine delivery vehicle.

AU - Roland, Kenneth L.

AU - Brenneman, Karen E.

PY - 2013/9

Y1 - 2013/9

N2 - Attenuated Salmonella vaccines can be administered orally to deliver recombinant antigens to mucosal surfaces inducing a protective immune response against a variety of targeted pathogens. A number of exciting new approaches and technologies for attenuated Salmonella vaccines have been developed recently. However, a disconnect remains between results obtained with mice in preclinical studies and results obtained in human clinical trials. This is due to an incomplete understanding of Salmonella Typhi interactions with human hosts and inadequate animal models available for study. In this review, the authors describe recent progress in identifying important differences underlying S. Typhi-host interactions, the development of novel approaches to vaccine design and six recent clinical trials evaluating Salmonella-vectored vaccines.

AB - Attenuated Salmonella vaccines can be administered orally to deliver recombinant antigens to mucosal surfaces inducing a protective immune response against a variety of targeted pathogens. A number of exciting new approaches and technologies for attenuated Salmonella vaccines have been developed recently. However, a disconnect remains between results obtained with mice in preclinical studies and results obtained in human clinical trials. This is due to an incomplete understanding of Salmonella Typhi interactions with human hosts and inadequate animal models available for study. In this review, the authors describe recent progress in identifying important differences underlying S. Typhi-host interactions, the development of novel approaches to vaccine design and six recent clinical trials evaluating Salmonella-vectored vaccines.

UR - http://www.scopus.com/inward/record.url?scp=84892517593&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84892517593&partnerID=8YFLogxK

M3 - Article

VL - 12

SP - 1033

EP - 1045

JO - Expert Review of Vaccines

JF - Expert Review of Vaccines

SN - 1476-0584

IS - 9

ER -